Initiation of ACESO’s COVID-19 adaptive platform trial (PROTECT-APT) received FDA approval. FHI Clinical is the CRO and IND sponsor across sites internationally
news & events
Check out what we’ve been up to and where we can connect!
February 2, 2023
Oracle is supporting CROs with no-obligation access to its Clinical One platform through its CRO Growth Initiative. Read why we chose the platform as our default eClinical system.
January 30, 2023
Members of the PREVAIL team, with their research partners, recently published results from clinical trials of three vaccine regimens against Zaire Ebola virus disease (EVD).
FHI Clinical collaborating with Tactical Therapeutics, Inc., to refine the protocol for the development of carboxyamidotriazole orotate (CTO) to treat respiratory diseases
December 21, 2022
FHI Clinical is contributing to the protocol design for a Phase 2 clinical trial to evaluate carboxyamidotriazole orotate (CTO), an asset from Tactical Therapeutics.
April 4, 2023
Join this roundtable, hosted by FHI Clinical, to discuss how we can use challenges and opportunities experienced during previous HIV vaccine development to inform future development efforts.